Page 10 - CBCMT-Pulse_Vol-2
P. 10
Funded Projects
Dr. Loganathan Rangasamy
Title: Radiolabelled Fibroblast Activation Protein Inhibitors as Novel Radio-
pharmaceuticals Targeting CAFs.
Funding Agency: Board of Research in Nuclear Sciences (BRNS).
Period: 2022-25.
Amount: INR 39,00,000.
Dr. Cheirmadurai Kalirajan
Title: Injectable Hydrogel Based Novel Therapeutics for the Treatment of Rheumatoid
Arthritis.
Funding Agency: DBT – India Alliance Early Career Fellowship.
Period: 2023-28.
Amount: INR 1,30,00,000.
CBCMT Pulse August 2022 Volume 2 8
